Antibiotic-Loaded Ultrahigh Molecular Weight Polyethylenes

Area of Science:

• Biomaterials Science
• Orthopedic Surgery
• Infectious Diseases

Background:

• Periprosthetic joint infections (PJI) are a significant complication following total joint replacement.
• Current treatments often involve antibiotic-loaded polymethylmethacrylate (PMMA) spacers, which are non-load-bearing.
• There is a need for functional implant materials that can also deliver antibiotics to prevent or treat PJI.

Purpose of the Study:

• To investigate the feasibility of incorporating various antibiotics into ultrahigh molecular weight polyethylene (UHMWPE).
• To assess the stability and drug release characteristics of antibiotic-loaded UHMWPE.
• To evaluate the in vitro antibacterial efficacy of UHMWPE against common PJI pathogens.

Main Methods:

• Antibiotics were incorporated into UHMWPE via compression molding with varying loading concentrations.
• Drug stability was analyzed using thermo-gravimetric analysis and nuclear magnetic resonance spectroscopy.
• Antibacterial efficacy was tested in vitro against Staphylococci, the primary cause of PJI.

Main Results:

• UHMWPE successfully incorporated a range of antibiotics, maintaining drug stability.
• Predicted intra-articular drug concentrations remained above the minimum inhibitory concentration for at least 3 weeks.
• In vitro testing demonstrated sufficient antibacterial activity against Staphylococci from a small fraction of the implant surface.

Conclusions:

• UHMWPE is a feasible material for developing functional, antibiotic-eluting implants for preventing or treating PJI.
• This approach offers a promising strategy to combine load-bearing functionality with localized antibiotic delivery.
• Targeted antibiotic elution from UHMWPE surfaces shows potential for combating Staphylococcal PJI effectively.